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ABSTRACT
Introduction. One of the complications 
which often occur in the liver cirrhosis is bleeding.  
Closely associated with Weighing of bleeding were 
disturbance haemostatic homeostasis disorders that 
commonly associated with impaired liver function. 
So that the necessary biomarkers to objectively 
measure the severity of liver cirrhosis. Fibrinogen is 
one of the clotting factors that can be used to 
determine the severity of liver cirrhosis. MELD 
score is the most excellent alternative of the Child-
Pugh score. MELD score can be used in patients 
with liver cirrhosis spacious ranges severity of 
disease and etiology even in patients whose 
cirrhosis are not clear why. Currently, there was not 
any data showed the correlation between the level of 
plasmatic fibrinogen and MELD score in the 
patients with liver cirrhosis. This study aimed to find 
the correlation between the levels of plasmatic 
fibrinogen and MELD score in the patients with liver 
cirrhosis.
Method. The design of this study was cross-
sectional. Samples were obtained by the consecutive 
sampling. Subjects of the study were the patients 
with liver cirrhosis who visited as outpatient and 
inpatient in the Gastroenterohepatology clinic of Dr. 
Sardjito hospital between November 2011 to 
October 2012, and who already met the inclusion 
and exclusion criteria. The correlation between the 
level of plasmatic fibrinogen and MELD score was 
assessed statistically using correlation test. The 
final result of correlation test was stated in the 
correlation coefficient (r).
Result. There were 40 subjects that met 
criteria, 28 male and 12 female, age average was 
53±12, 51. Cause of cirrhosis was viral hepatitis B 
as much 16 (40, 0%) subject, hepatitis C 11 (27,5%) 
subject and non viral 13 (32,5%) subject. Subjects 
with ascites are 19 (47, 5%) and without ascites are 
20 (52.5%). Bleeding with 30 (80.0%) subjects, 10 
(20, 0%) without bleeding. Mean of plasma 
fibrinogen was 198 ± 102, 89 mg / dl, meanwhile the 
MELD score was 17, 05 ± 8.79. Spearman 
correlation coefficients between fibrinogen and 
MELD score was r = -0,404(p = 0,010).
Conclusion.  In conclusion, there was a 
negative correlation between plasma fibrinogen and 
MELD score in liver cirrhosis patients. 
Keywords:   liver cirrhosis, fibrinogen, MELD score   
 INTRODUCTION 
Cirrhosis of the liver is a journey final 
pathology of various liver diseases, in which the 
liver is found liver damage characterized by fibrosis.  
Cirrhosis of the liver can lead to around 35,000 
deaths per year in the United States (U.S.), which is 
the ninth leading cause of death in the U.S. 
(Kusumobroto 2007). In Peru due to liver cirrhosis 
mortality rate reached 10.45 per 100,000 
10  population. Mortality due to liver cirrhosis has 
increased from 6 per 100,000 populations in 1993 to 
12.7 per 100,000 populations in the year 2000. 6 One 
common complication is bleeding in liver cirrhosis. 
Severity of bleeding, closely related to hemostasis 
disorders, hemostasis disorders are usually nothing 
to do with impaired liver function. Levels of blood 
clotting factors, including fibrinogen, is one of the 
parameters that can be used to determine the severity 
1of liver cirrhosis.  Model for end-stage liver disease 
(MELD) is the best alternative of the Child-Pugh 
score. This score was formed as a very serious 
challenge to replace Child-Pugh score and 
overcoming its limitations. MELD score is useful in 
patients with liver cirrhosis wide range of disease 
severity and etiology even in patients with cirrhosis 
2is not causes clear.  
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METHOD 
The study design was cross-sectional. A 
study was conducted in the clinic and hospital ward 
Medicine Unit Sardjito, Yogyakarta. The study 
began in November 2011 to October 2012. Subjects 
were patients with liver cirrhosis treatment in 
gastroenterology clinic or hospitalized in the 
Internal Medicine ward Sardjito Hospital who meet 
inclusion and exclusion criteria. Fibrinogen is a 
plasma protein that is synthesized by parenchyma 
cells fibrinogen tests using serum or plasma samples 
as much as 3 cc of heparin stored at -20 º C. 
Reference values for normal fibrinogen level is 200-
400 mg / dL. MELD score is calculated according to 
the formula = 3.78 [Ln serum bilirubin (mg / dL)] + 
11.2 [Ln INR] + 9.57 [Ln serum creatinine (mg / dl)] 
+ 6, 45. Course of study can be explained in Figure 1. 
Figure 1. Course of the study
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Table 1. Characteristic Subject
 
N = total subject of research ; SD = standard deviation; INR = International Normalized Ratio; MELD = Model of End 
Stage liver disease 
Variable n (%) Mean ± SD 
Sex 
Man 
Woman 
Age 
Cause cirrhosis 
Hepatitis B 
Hepatitis C 
Non viral 
Ascites 
Yes 
No 
Bleeding
 
Yes
 
No
 
Plasma fibrinogen level (mg/dl)
 
MELD score
 
 
28 (70,0) 
12 (30,0) 
 
 
16 (40,0) 
11 (27,5) 
13 (32,5) 
 
19 (47,5) 
20 ( 52,5)  
30 (80,0)
 
10 (20,0)
 
 
 
 
53±12,51 
 
 
 
 
 
 
 
 
 
 
198 ± 102,89
 
17,05 ± 8,79
Table 2. Comparison clinical between fibrinogen level < 200 mg/dl and fibrinogen level > 200 mg/dl
MELD = Model of End Stage Liver Disease; RP = rasio prevalensi; IK = confiden interval; *= uji t test unpired ; # = uji Chi 
square; $ = Uji Fisher 
Variable Fibrinogen level 
< 200 mg/dl 
Mean±SB 
(n=23) 
Fibrinogen level  
mean±SB 
(n=17) 
P 95%IK 
Sex
 
Man (n%)
 
Women (n%)
 
Age
 
Bleeding
 
Yes (n%)
 
No (n%)
 
 
15 (65,2)
 
8 (34,8)
 
54,74 ±10,32
 
 
21 (91,3)
 
2 (8,7)
 
 
13 (76,5)
 
4 (23,5)
 
51,24 ± 15,68
 
 
11 (64,7)
 
6 (35,5)
 
 
0.443#
 
 
0,388*
 
 
0,053$
 
 
0.14-2,36
 
 
-4,62-11,63
 
 
-,98-33,24
 
> 200 mg/dl
Table 3. Mean difference fibrinogen levels based on severity of MELD score
 Fibrinogen level  
MELD score  Mean±SD  P 95% IK 
<10  
10-19  
20-29  
30-39  
>40  
339,00 ± 207,0  
200,35 ± 85,8  
190,26 ± 78,5  
111,60 ± 96,0  
200,00  
0,180* -175,28-853,28 
165,65-235,04 
92,69-287,82 
-7,66-230,86 
? = uji Kruskal Walis
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DISCUSSION  
Study subjects who met the inclusion 
criteria obtained from 40 patients. Consisted of 28 
(70.0%) by the subjects of male and 12 (30.0%) 
female. This is similar to a previous study that found 
male subjects are more than the female subjects. 
Previous research conducted to get male cirrhotic 
patients as much as 64%. The mean age of study 
subjects was 53 ± 12.51 years. Based on 
epidemiological data, cirrhosis of the liver usually 
inflicted on those who are entering the age of five 
3decades or six.  Cause cirrhosis of the liver in the 
study of hepatitis B virus infection by 16 (40.0%), 
hepatitis C infection were 11 (27.5%) and not 
hepatitis B virus infection and C were 13 (32.5%). 
Previous research conducted Nurdjanah, (2006) 
Indonesian data showed the cause of cirrhosis of the 
liver are hepatitis B virus (40-50%), hepatitis C 
virus (30-40%) and 10-20% the cause is unknown 
and not including group B and C viruses. It was 
found bleeding subjects with 30 (80.0%) and 10 
(20.0%) without bleeding. Sulaiman, (1990) found 
bleeding manifestations of liver cirrhosis, 56.2% 
melena, hematemesis 50.6%, 27% bleeding gums 
and epistaxis 13.2%. Tambunan, (2006) reported on 
121 patients with liver cirrhosis 75 cases (61.9%) 
experienced bleeding. Average fibrinogen levels in 
this study were 198 ± 102.89 mg / dL. The reference 
value in this study was 200-400 mg / dL, so we can 
conclude that the mean of fibrinogen levels below 
the normal range, although some subjects showed 
normal or increased values above normal values. 
The mean MELD score of study subjects was 17.05 
± 8.79. This result is higher than the previous studies 
that found a mean MELD score 9.7 ± 9, 2 and 
median MELD Score 9 (4-14). 4 This research study 
subjects were grouped into two groups based on the 
value of fibrinogen levels. The first group is those 
with fibrinogen levels less than normal value is < 
200 mg / dl and the second group are those with a 
normal fibrinogen level is = 200 mg / dl. Conducted 
Table 4. Correlation of test results with fibrinogen levels MELD score
 Correlation coefficient 
Spearman ( r ) 
P  
Fibrinogen level 
MELD score 
-0,404 0,010 
clinical and laboratory data comparisons between 
the two groups as shown in Table 2. Obtained 23 
subjects in the first group comprised 15 men 
(65.2%) and 8 women (34.8%), the second group 
comprised 13 men (76.5%) and 4 women (23.5%). 
The average age of the first group was 54.74 ± 10.32 
years in the second group 51.24 ± 15.08. There was 
no difference in the two groups according to age. 
The first group of 23 subjects obtained with clinical 
bleeding were 21 (91.3%) subjects and not bleeding 
2 (8.7%) subjects, clinical bleeding, which is much 
more than the second group of 17 subjects with 
bleeding 11 (64, 7%) and no bleeding 6 (35.3%) but 
this did not reach statistical significance (p = 0.053). 
Table 3 shows the mean fibrinogen levels based on 
the severity of the value of MELD score. The mean 
MELD group fibrinogen levels <10 = 339.00 ± 
207.0 mg / dl; MELD 10-19 = 200.35 ± 85.8 mg / dl; 
MELD 20-29 = 190.26 ± 78.5 mg / dl; MELD 30-39 
= 116.60 ± 96.0 mg / dl, and MELD> 40 = 200.00 
mg / dl. In this study, the mean fibrinogen levels 
were found non-significant (p = 0.180). In each 
group according to the severity of which is rated as 
MELD score <40 obtained mean difference 
decreased levels of fibrinogen followed in 
accordance with the increase in the value of MELD 
score. The group with MELD scores > 40 decreased 
levels of fibrinogen are not in accordance with their 
respective groups based on the severity of the 
MELD score, in this study obtained a sample with a 
mean value of fibrinogen levels equal to 200 mg / dl. 
There are several possible causes for this difference. 
The first possibility, the presence of co morbidities 
that accompany the research subject is an infection. 
Co morbidities in these patients obtained a urinary 
tract infection. Fibrinogen is an acute phase 
reactant, the level will rises several-fold in the 
presence of infection. The second possibility is age. 
The mean age in this study was 53 ± 12.51. Patient 
age was 56 years approaching old age. Old age 
affects levels of fibrinogen. The third possibility is 
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hemolysis in samples that can affect test results. 
Table 4 shows the Spearman correlation test plasma 
fibrinogen levels on MELD score, which there is a 
negative correlation decreased levels of fibrinogen 
and an increase in MELD score (r = -0.404, p = 
0.010), (weak force). This means that the plasma 
fibrinogen level correlated with MELD scores. This 
relationship illustrates that most of the subjects in 
this study were patients who had advanced liver 
cirrhosis. Fibrinogen levels decreased in patients 
with liver cirrhosis according to the severity of the 
disease where it can determine the prognosis of 
patients with liver cirrhosis. The results of this study 
are also consistent with research on fibrinogen by 
Arif et al., (2002) In a study on 82 patients with liver 
cirrhosis compared with 40 normal patients as 
controls found a decrease in fibrinogen levels 
compared to mean controls, mild decline found in 
early liver cirrhosis and a higher reduction in 
advanced stage liver cirrhosis. 
Figure 2. MELD scores linear regression with plasma fibrinogen levels 
Performed linear regression is to see the 
effect of the MELD score on levels of fibrinogen. 
Equation fibrinogen = 276.2 to 4.54 * MELD score, 
the R-square is 0.14, which means the equation can 
only predict as much as 14% decrease in fibrinogen 
levels are associated with the increased MELD 
score. 
CONCLUSION 
There is a negative correlation between 
plasma fibrinogen levels in patients with MELD 
scores of liver cirrhosis. Obtained decreased levels 
of fibrinogen, followed by an increased in MELD 
score.
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